Manufacturers can support the ICD-10 transition
Despite continued rumblings of uncertainty surrounding the implementation of ICD-10, pharmaceutical manufacturers should continue preparing to reduce the risk for provider claims challenges, payer errors, and other access concerns that could compromise continuity of therapy. While healthcare facilities and physician […]
Read More